Finance

Beta
Lists
CSCI:TSE
COSCIENS Biopharma Inc
CA$2.51
-8.73%
(-0.24) 1D
Jun 4, 9:30:02 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CSCI...
Open
CA$2.51
High
CA$2.51
Low
CA$2.51
Mkt. cap
7.99M
Avg. vol.
2.04K
Volume
100.00
P/E ratio
1.37
52-wk high
CA$6.00
52-wk low
CA$1.10
EPS
CA$1.83
Beta
1.52
Shares outstanding
3.18M
No. of employees
28
Open
CA$2.51
High
CA$2.51
Low
CA$2.51
Mkt. cap
7.99M
Avg. vol.
2.04K
Volume
100.00
P/E ratio
1.37
52-wk high
CA$6.00
52-wk low
CA$1.10
EPS
CA$1.83
Beta
1.52
Shares outstanding
3.18M
No. of employees
28
News stories
From sources across the web
About COSCIENS Biopharma Inc
CEO-
Employees28
Founded1990
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websitecosciensbio.com
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
- / -
Revenue / Est. (USD)
1.89M / -
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.75M
1.48M
1.77M
1.89M
Cost of goods sold
1.78M
938.00K
1.16M
1.10M
Cost of revenue
1.78M
938.00K
1.16M
1.10M
Research and development expenses
690.00K
527.00K
599.00K
176.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.64M
2.10M
2.40M
1.35M
Operating expense
3.33M
2.63M
3.00M
1.52M
Total operating expenses
5.10M
3.57M
4.15M
2.62M
Operating income
-2.35M
-2.08M
-2.39M
-730.00K
Other non operating income
-326.00K
522.00K
240.00K
562.00K
EBT including unusual items
-2.70M
-1.82M
-2.17M
-183.00K
EBT excluding unusual items
-2.70M
-1.58M
-2.17M
-183.00K
Income tax expense
1.00K
-
10.00K
-
Effective tax rate
-0.04%
-
-0.46%
-
Other operating expenses
-
-
-
-
Net income
-2.70M
-1.82M
-2.18M
10.76M
Net profit margin
-98.25%
-122.66%
-123.61%
569.76%
Earnings per share
-
-
-
-
Interest and investment income
83.00K
57.00K
37.00K
20.00K
Interest expense
-23.00K
-43.00K
-32.00K
-46.00K
Net interest expenses
60.00K
14.00K
5.00K
-26.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.07M
-1.80M
-2.36M
-389.00K
Gain or loss from assets sale
-
-
-
-11.28M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer